No abstract

No abstract

No abstract

The world is anticipating the leaders and planners of future energy market to come up with some tangible and sustainable solution, to deal with the dependence and reliance of humankind over hydrocarbon resources for their energy requirements, not only to cope with the exponentially growing demand but also to the hazards and risks to the mother nature due to carbon emission. With strong commitment from government of Abu Dhabi, ADWEA (Abu Dhabi Water & Electricity Authority) commences number of initiatives, fully supported by MASDAR (The renewable energy resource provider in UAE) and TRANSCO (Abu Dhabi Transmission & Dispatch Company).This paper will provide an insight of the activities going around UAE's power sector in this perspective and how dispatching and regulatory aspects are being tackled here with renewable resources. The paper will also look into the in depth analysis of challenges that power system operator will face in integration and consequently in operational phases of this kind of power production. Ways and means to attend these issues are suggested in background of international experiences and best practices. With the commitment from the leaders of the country by 2020 around 7% of the total required energy demand will be coped with renewable, it is a colossal task for TRANSCO and ADWEA to gear up and prepared to successfully support Abu Dhabi government vision.

No abstract

The purpose of this article is to report on the newly recognized life threating gastrointestinal complications of Corona virus infection in the form of bowel ischemia and ischemic bowel perforation. In a retrospective observational study at Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, United Arab Emirates during the period between March and May 2020. All COVID-19 positive patients with free intra peritoneal air were included; total of five patients met our inclusion criteria during the study period, all patients were admitted to the intensive care unit for mechanical ventilation and management of severe COVID 19 related respiratory complications. COVID-19 status was based on a positive PCR nasopharyngeal swab supported by typical radiological findings on either chest X-ray (CXR) or CT Chest. Free air under the diaphragm was radiologically confirmed in all patients. Patients' demographics and co-morbidities were reviewed. Four patients underwent an emergency surgical intervention confirming ischemic perforation of the right colon. The caecum was identified as the starting point of ischemia with variable distal extension into the ascending colon and the hepatic flexure. One patient unfortunately demised prior to surgery due to severe septic complications. These findings highlight the importance of paying attention to COVID 19 patients with sudden clinical deterioration and raise the extent of the gastrointestinal manifestation of COVID-19 infection beyond simple diarrhea and abdominal pain.

Locally advanced and borderline resectable pancreatic cancers are being increasingly recognized as a result of significant improvements in imaging modalities. The main tools used in diagnosis of these tumors include endoscopic ultrasound, computed tomography, magnetic resonance imaging, and diagnostic laparoscopy. The definition of what constitutes a locally advanced or borderline resectable tumor is still controversial to this day. Borderline resectable tumors have been treated with neoadjuvant therapy approaches that aim at reducing tumor size, thus improving the chances of an R0 resection. Both chemotherapy and radiotherapy (solo or in combination) have been used in this setting. The main chemotherapy agents that have shown to increase resectability and survival are FOLFORINOX (a combination of folinic acid, fluorouracil, irinotecan, and oxaliplatin) and gemcitabine-nab-paclitaxel. Surgery on these tumors remains a significantly challenging task for pancreatic surgeons. More studies are needed to determine the best agents to be used in the neoadjuvant and adjuvant settings, biologic markers for prognostic and operative predictions, and validation of previously published retrospective results.